137 related articles for article (PubMed ID: 18218559)
21. Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis.
Wakuta A; Nouso K; Kariyama K; Nishimura M; Kishida M; Wada N; Mizushima T; Higashi T; Tanimoto M
Oncology; 2011; 81(1):39-44. PubMed ID: 21912196
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
23. [Avoidance of platelet transfusion with readministration of lusutrombopag before radiofrequency ablation in hepatocellular carcinoma:a case report].
Kotani S; Kohge N; Tsukano K; Ogawa S; Yamanouchi S; Kusunoki R; Aimi M; Miyaoka Y; Fujishiro H
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(10):1853-1859. PubMed ID: 28978885
[TBL] [Abstract][Full Text] [Related]
24. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma.
Takada Y; Kurata M; Ohkohchi N
Int J Clin Oncol; 2003 Oct; 8(5):332-5. PubMed ID: 14586761
[TBL] [Abstract][Full Text] [Related]
25. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
[TBL] [Abstract][Full Text] [Related]
27. Case report: multiple cancers: hepatocellular carcinoma and adenocarcinomas of the common bile duct and the gall-bladder in a woman with primary biliary cirrhosis.
Imada J; Hoshino H; Nishimura D; Morita K; Yoshida N; Katada N; Sano H; Kato K; Mori N
J Gastroenterol Hepatol; 1996 Jun; 11(6):546-50. PubMed ID: 8792308
[TBL] [Abstract][Full Text] [Related]
28. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
[TBL] [Abstract][Full Text] [Related]
29. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
30. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
Romero Gutiérrez M; Ruano Díaz L; Muñoz López D; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; de la Cruz Pérez G; Gómez Rodríguez R
Gastroenterol Hepatol; 2015 Feb; 38(2):54-61. PubMed ID: 25499846
[TBL] [Abstract][Full Text] [Related]
31. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 years.
Giorgio A; Merola MG; Montesarchio L; Merola F; Gatti P; Coppola C; Giorgio V; Calisti G
Br J Radiol; 2017 Jun; 90(1074):20160804. PubMed ID: 28402124
[TBL] [Abstract][Full Text] [Related]
33. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
Kim JS; Kim W; So YH; Yu SJ; Kim BG
J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
[TBL] [Abstract][Full Text] [Related]
34. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.
Trivedi PJ; Lammers WJ; van Buuren HR; Parés A; Floreani A; Janssen HL; Invernizzi P; Battezzati PM; Ponsioen CY; Corpechot C; Poupon R; Mayo MJ; Burroughs AK; Nevens F; Mason AL; Kowdley KV; Lleo A; Caballeria L; Lindor KD; Hansen BE; Hirschfield GM;
Gut; 2016 Feb; 65(2):321-9. PubMed ID: 25567117
[TBL] [Abstract][Full Text] [Related]
35. [Radiofrequency ablation for hepatocellular carcinoma].
Inagaki M; Yagi T; Sadamori H; Matsuda H; Matsukawa H; Ishikawa T; Tanaka N; Mimura H; Yasui K; Kanazawa S
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2242-5. PubMed ID: 12484046
[TBL] [Abstract][Full Text] [Related]
36. A case of gouty arthritis following percutaneous radiofrequency ablation for hepatocellular carcinoma.
Choi DH; Lee HS
World J Gastroenterol; 2010 Feb; 16(6):778-81. PubMed ID: 20135729
[TBL] [Abstract][Full Text] [Related]
37. Local recurrence of hepatocellular carcinoma after radiofrequency ablation.
Liao WJ; Shi M; Chen JZ; Li AM
World J Gastroenterol; 2010 Oct; 16(40):5135-8. PubMed ID: 20976853
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection.
Tajiri K; Baba H; Kawai K; Minemura M; Yasumura S; Takahara T; Sugiyama T
J Gastroenterol Hepatol; 2016 Jul; 31(7):1291-9. PubMed ID: 26729319
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma.
Lencioni R; Della Pina C; Bartolozzi C
Abdom Imaging; 2005; 30(4):401-8. PubMed ID: 16132439
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of laparoscopic radiofrequency ablation of hepatocellular carcinoma.
Okabayashi T; Kobayashi M; Akimori T; Akisawa N; Iwasaki S; Onishi S; Araki K
Surg Technol Int; 2005; 14():177-81. PubMed ID: 16525971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
